| Literature DB >> 25426633 |
Bora Koc1, Huseyin Yuce Bircan2, Gokhan Adas1, Ozgur Kemik3, Adem Akcakaya1, Alpaslan Yavuz4, Servet Karahan1.
Abstract
BACKGROUND: ERCP has a complication rate ranging between 4% and 16% such as post-ERCP pancreatitis, hemorrhage, cholangitis and perforation. Perforation rate was reported as 0.08% to 1% and mortality rate up to 1.5%. Besides, injury related death rate is 16% to 18%. In this study we aimed to present a retrospective review of our experience with post ERCP-related perforations, reveal the type of injuries and management recommendations with the minimally invasive approaches.Entities:
Mesh:
Year: 2014 PMID: 25426633 PMCID: PMC4245110 DOI: 10.1371/journal.pone.0113073
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Classification of ERCP-Related Perforations [19].
| Type | Definition |
|
| Lateral or medial duodenal wall perforation (endoscope related) |
|
| Periampullary perforations (sphincterotomy related) |
|
| Ductal and duodenal perforations due to endoscopic instruments (not guide-wire) |
|
| Presence of retroperitoneal air due to guide-wire |
Figure 1The figure shows the mean time of diagnosis after ERCP procedure (hours).
Successful Nonsurgical Management of ERCP-Related Perforations.
| Age | Gender | ERCP indication | Type of perforation | Time Between ERCP and diagnosis (hour) | Diagnosis of perforation | Radiologic Findings | LOS (day) | Outcome |
| 51 | F | CBD stones | II | 0 h | ERCP | Minimal contrast extravasation | 12 d | Survived |
| 78 | M | CBD stones | II | 1 h | CT | Retroperitoneal air | 11 d | Survived |
| 69 | F | Cholangitis | III | 2 h | CT | Intra-and retroperitoneal air | 9 d | Survived |
| 54 | F | CBD stones | II | 1 h | CT, USG | Intra-and retroperitoneal air | 14 d | Survived |
| 68 | M | Cholangitis | IV | 1 h | CT | Retroperitoneal air | 10 d | Survived |
| 66 | F | CBD Stones | III | 0 h | ERCP | Minimal contrast extravasation | 11 d | Survived |
| 57 | F | CBD stones | II | 2 h | CT | Retroperitoneal air | 11 d | Survived |
| 49 | F | Cholangitis | II | 1 h | CT | Intra-and retroperitoneal air | 9 d | Survived |
| 28 | F | CBD stones | II | 0 h | ERCP | Contrast extravasation | 12 d | Survived |
| 34 | F | CBD stones | III | 2 h | CT | Retroperitoneal air | 8 d | Survived |
| 31 | F | CBD Stones | II | 0 h | CT | Intra-and retroperitoneal air | 9 d | Survived |
| 58 | M | Benign biliary stricture | III | 1 h | CT, USG | Intra-and retroperitoneal air, fluid collection | 12 d | Survived |
| 72 | M | Pancreas Head Cancer | IV | 0 h | CT | Retroperitoneal air | 6 d | Survived |
| 68 | F | Benign biliary stricture | III | 1 h | CT | Free air, fluid collection | 11 d | Survived |
ERCP: Endoscopic Retrograde Cholangiopancreatography, CT: Computer Tomography, USG: Ultrasonography LOS: Length of Stay.
Failed Non-Surgical Management of ERCP-Related Perforations.
| Age | Gender | ERCP indication | Type of perforations | Time between ERCP and diagnosis (hour) | Time between ERCP and Operation (hour) | Type of Operation | LOS (day) | Outcome |
| 54 | F | Cholangitis+CBD stone | II | 0 h | 24 h | Laparoscopic cholecyctectomy+LCBDE+T-Tube+drainage | 18 d | Survived |
| 45 | M | CBD stones | II | 12 h | 36 h | Laparoscopic cholecyctectomy+LCBDE+Stoneextraction+T-Tube+drainage | 3 d | Ex (AMI) |
| 54 | F | Cholangitis+CBD stone | II | 72 h | 108 h | Laparoscopic cholecyctectomy+LCBDE+drainage | 10 d | Survived |
| 57 | F | CBD stones | III | 24 h | 96 h | Laparoscopic cholecyctectomy+Stone extraction+LCBDE+T-Tube | 11 d | Survived |
| 71 | F | CBD stones | II | 18 h | 48 h | Laparoscopic cholecyctectomy+LCBDE+T-Tube+drainage | 12 d | Survived |
| 63 | M | Cholangitis+CBD stone | III | 12 h | 48 h | Laparoscopic cholecyctectomy+LCBDE+Trans-Cystic drain | 12 d | Survived |
ERCP: Endoscopic Retrograde Cholangiopancreatography, LOS: Length of Stay, AMI: Acute Myocardia Infarcts, Ex:Exitus, LCBDE: Laparoscopic common bile duct exploration.
Primary Minimal Invasive Surgical Management of ERCP-Related Perforations.
| Age | Gender | ERCP indication | Type of Perforation | Time Between ERCP and diagnosis (hour) | Time between ERCP and Operation (hour) | Type of Operation | LOS (day) | Outcome |
| 42 | M | Cholangitis+CBD Stones | II | 0 h | 1 h | LCBDE+T-Tube+drainage | 10 d | Survived |
| 37 | F | Cholangitis+CBD Stones | II | 0 h | 1 h | Laparoscopic cholecyctectomy+LCBDE+Trans-cytic drain+drainage | 7 d | Survived |
| 39 | M | Cholangitis+CBD Stones | III | 2 h | 3 h | LCBDE+T-Tube | 8 d | Survived |
| 40 | M | Cholangitis+CBD Stones | II | 1 h | 2 h | LCBDE+T-Tube+drainage | 8 d | Survived |
| 43 | M | Cholangitis+CBD Stones | II | 0 h | 1 h | Laparoscopic cholecyctectomy+LCBDE+T-Tube+drainage | 13 d | Survived |
| 35 | F | Cholangitis | II | 2 h | 3 h | Laparoscopic cholecyctectomy+LCBDE+T-Tube+drainage | 4 d | Survived |
ERCP: Endoscopic Retrograde Cholangiopancreatography, LOS: Length of Stay, LCBDE: Laparoscopic common bile duct exploration.
Failed primary minimal invasive surgical management of ERCP-related perforations.
| Age | Gender | ERCP indication | Type of Perforation | Time Between ERCP and diagnosis (hour) | Time between ERCP and Operation (hour) | Type of Operation | LOS (day) | Outcome |
| 63 | F | CBD stones | II | 0 h | 1-) 2 h 2-) 72 h | Laparoscopic cholecyctectomy+LCBDE+Stone extraction+T-Tube+drainage Re-operation: Pyloric exclusion+T-Tube revision+gastrojejunostomy | 14 d | Survived |
| 68 | F | Pancreas head cancer+liver metastasis | III | 1 h | 1-) 2 h 2-) 36 h | LCBDE+T-Tube+drainage Re-operation: explorative laparotomy+intra-abdominal abscess+drainage | 10 d | Ex (Sepsis) |
ERCP: Endoscopic Retrograde Cholangiopancreatography, LOS: Length of Stay, LCBDE: Laparoscopic common bile duct exploration.
Reported perforation rates with ERCP.
| Study | Length of Study | Number of ERCP's | Perforations | Operations | Mortality | Year |
|
| 10 years | 750 | 10(1.3) | 10(100%) | 2(20%) | 1996 |
|
| 2 years | 3356 | 28(0.83%) | 10(35.7%) | 4(14.3%) | 1998 |
|
| 5 years | 1413 | 14(0.99%) | 9(64.3%) | 2(14.3%) | 2000 |
|
| 9 years | 4030 | 18(0.45%) | 18(100%) | 3(16.7%) | 2003 |
|
| 2 years | 1177 | 13(1.1%) | 2(15.4%) | 1(7.7%) | 2004 |
|
| 6 years | 6620 | 30(0.45%) | 10(33.3%) | 5(16.7%) | 2006 |
|
| 11 years | 12427 | 76(0.6%) | 22(28.9%) | 5(6.6%) | 2007 |
|
| 12 years | 11497 | 16(0.14%) | 11(68.8%) | 1(6.3%) | 2009 |
|
| 13 years | 12817 | 24(0.2%) | 10(41.7%) | 1(4.2%) | 2009 |
|
| 2 years | 423 | 1(0.2%) | 1(100%) | 0 (0%) | 2014 |
|
| 7 years | 2837 | 3(0.11%) | 1(0.035) | 0 (0%) | 2014 |
|
| 6 years | 2972 | 28(0.94%) | 20(71.4%) | 2 (7.1%) | 2014 |
ERCP: Endoscopic Retrograde Cholangiopancreatography.
Figure 2A simple management algorithm for the ERCP-related perforations.